Onyx Pharmaceuticals is close to selling itself to larger rival Amgen after the cancer drugmaker's high stock price discouraged other companies from making a counter offer, according to three people ... more 
Onyx Pharmaceuticals is close to selling itself to larger rival Amgen after the cancer drugmaker's high stock price discouraged other companies from making a counter offer, according to three people familiar with the matter. Terms of an agreement have yet to be finalized, but the companies are negotiating a price of $130 per share, or nearly $9.5 billion. A former Libyan militia commander denied charges filed in U.S. federal court accusing him of being involved in an attack that killed a U.S. ambassador and three other Americans. Egypt's military-backed interim leadership proclaimed that a crackdown against two protest sites is inevitable, saying that nearly two weeks of foreign diplomatic efforts to peacefully resolve its standoff with the Muslim Brotherhood have failed. less 
1 / 26
Wochit
Wed, Aug 7, 2013 1:43 PM EDT